ArticleLeukemia2023
Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 European Conference on Infections in Leukaemia (ECIL 9).
Registry-linked trialOpen access · hybridAbstract readLetter
In one paragraph
Article in Leukemia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07346820 (VDJ-recombination of the B-cell Receptor Following Hematopoietic Stem Cell Transplantation, an Observational Study), which is not on this map. Cited by 26 papers.
0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
9.0field-weighted citation impact, top 2% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
VDJ-recombination of the B-cell Receptor Following Hematopoietic Stem Cell Transplantation, an Observational Study
Who cites it
26 citing papers in PubMed, 39 citations in OpenAlex.
- Analysis of factors influencing SARS-CoV-2 infection and outcomes in patients with chronic lymphocytic leukemia during the burst of COVID-19 epidemic.BMC cancer · 2026Article
- Time to anti-cancer treatment resumption after SARS-CoV-2 infection in patients with active haematological diseases undergoing combined antiviral treatments.The Journal of antimicrobial chemotherapy · 2025Observational
- Role of remdesivir for the treatment of COVID-19 in patients with hematologic malignancy-A narrative review and expert opinion.European journal of clinical investigation · 2025Review
- Review
- Decoding Immunodeficiencies with Artificial Intelligence: A New Era of Precision Medicine.Biomedicines · 2025Review
- COVID-19 prior to hematopoietic stem cell transplantation increases the risk of acute graft-versus-host disease but does not affect overall mortality.Bone marrow transplantation · 2025Article
- Review
- Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023-2024: EPICOVIDEHA-EPIFLUEHA Report.American journal of hematology · 2025Article
- BNT162b2 mRNA vaccination affects the gut microbiome composition of patients with follicular lymphoma and chronic lymphocytic leukemia.Biomarker research · 2025Article
- Convalescent plasma therapy and long-term SARS-COV-2 antiviral immune response in a prospective cohort of patients with COVID-19.Current research in microbial sciences · 2025Article
- Remdesivir-Associated Survival Outcomes Among Immunocompromised Patients Hospitalized for COVID-19: Real-world Evidence From the Omicron-Dominant Era.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024Article
- Greater preservation of SARS-CoV-2 neutralising antibody responses following the ChAdOx1-S (AZD1222) vaccine compared with mRNA vaccines in haematopoietic cell transplant recipients.British journal of haematology · 2024Article
- [Allogeneic hematopoietic stem cell transplantation during the normalization stage of COVID-19 management].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2024Article
- Article
- Reply to the Comment on: "Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry".Haematologica · 2024Article
- Article
- Effectiveness of Paxlovid in the treatment of the SARS-CoV-2 Omicron variant infection in children with hematologic malignancies: a retrospective cohort study.Translational cancer research · 2024Article
- Patients with multiple myeloma infected with COVID-19 during autologous stem cell transplantation.Infectious agents and cancer · 2024Article
- Outcomes in Hematopoietic Cell Transplant and Chimeric Antigen Receptor T-Cell Therapy Recipients With Pre-Cellular Therapy SARS-CoV-2 Infection.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024Article
- Managing and treating COVID-19 in patients with hematological malignancies: a narrative review and expert insights.Clinical and experimental medicine · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors at 19 institutions in 9 countries.
Simone Cesaro *Paediatric Haematology-Oncology, Department of Mother and Child, Azienda Ospedaliera Universitaria Integrata, Verona, Italy. simone.cesaro@aovr.veneto.it.ORCID 0000-0002-8698-9547
Malgorzata Mikulska *Division of Infectious Diseases, Department of Health Sciences (DISSAL), University of Genova, Genova, Italy.ORCID 0000-0002-5535-4602
Hans H HirschTransplantation & Clinical Virology, Department of Biomedicine, University of Basel, Basel, Switzerland.ORCID 0000-0003-0883-0423
Jan StyczynskiDepartment of Paediatric Haematology and Oncology, Jurasz University Hospital, Nicolaus Copernicus University Torun, Collegium Medicum, Bydgoszcz, Poland.ORCID 0000-0002-3158-119X
Sylvain MeylanInfectious Diseases Service, Internal Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.ORCID 0000-0001-6319-2423
Catherine CordonnierHaematology Department, Henri Mondor Hospital, APHP, and University Paris Est-Créteil, Paris, France.
Davide NavarroMicrobiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.ORCID 0000-0003-3010-4110
Marie von Lilienfeld-ToalKlinik fur Innere Medizin II (Haematologie/Oncologie), Universitatsklinikum Jena, Jena, Germany.
Varun MehraDepartment of Haematology, King's College Hospital NHS Foundation Trust, London, United Kingdom.ORCID 0000-0001-6572-0971
Francesco MarchesiHaematology Unit, Department of Research and Clinical Oncology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.ORCID 0000-0001-6353-2272
Caroline BessonService d'Hematologie Oncologie, Centre Hospitalier de Versailles, Le Chesnay, Villejuif, France.ORCID 0000-0003-4364-7173
Raul Cordoba MasculanoFundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain.
Gernot BeutelDepartment for Haematology, Haemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.ORCID 0000-0001-6758-6104
Herman EinseleDepartment of Internal Medicine II, University of Würzburg, Würzburg, Germany.
Johan MaertensHaematology Department, University Hospitals Leuven, KU Leuven, Leuven, Belgium.ORCID 0000-0003-4257-5980
Rafael de la CamaraDepartment of Haematology, Hospital de la Princesa, Madrid, Spain.ORCID 0000-0002-8189-5779
ECIL 9
Per Ljungman *Division of Haematology, Department of Medicine, Huddinge, Karolinska Institute, Stockholm, Sweden.ORCID 0000-0002-8281-3245
Livio Pagano *Institute of Haematology, Faculty of Medicine and Surgery, "Sacro Cuore" Catholic University, Rome, Italy.
Hospital Universitario de La Princesa · ESUniversità Cattolica del Sacro Cuore · ITAzienda Ospedaliera Universitaria Integrata Verona · ITCentre Hospitalier de Versailles · FRHospital Universitario Fundación Jiménez Díaz · ESIstituti di Ricovero e Cura a Carattere Scientifico · ITJena University Hospital · DEKarolinska Institutet · SEKing's College Hospital NHS Foundation Trust · GBKU Leuven · BELeibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. - Hans-Knöll-Institut (HKI) · DEMedizinische Hochschule Hannover · DENicolaus Copernicus University · PLOspedale Policlinico San Martino · ITUniversitat de València · ESUniversité Paris-Est Créteil · FRUniversity of Basel · CHUniversity of Lausanne · CHUniversity of Würzburg · DE
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
COVID-19Hematologic NeoplasmsHematopoietic Stem Cell TransplantationLeukemiaReceptors, Chimeric AntigenHumansReceptors, Chimeric Antigen
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
NCT07346820ClinicalTrials.gov
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.